Nonviral gene therapy: the promise of genes as pharmaceutical products.
about
Dynamics of transient pores in stretched vesicles.Phosphorothioate oligonucleotides induction into experimental choroidal neovascularization by HVJ-liposome system.A combinatorial approach to the discovery of efficient cationic peptoid reagents for gene delivery.A polymer library approach to suicide gene therapy for cancer.Gene therapy and dermatology: more than just skin deep.Method to eliminate linear DNA from mixture containing nicked circular, supercoiled, and linear plasmid DNA.Intracellular mRNA regulation with self-assembled locked nucleic acid polymer nanoparticlesLipoplexes and tumours. A review.Tailoring new gene delivery designs for specific targets.BioShuttle mobility in living cells studied with high-resolution FCS & CLSM methodologiesNew tools to trace populations of inflammatory cells in the CNS.Molecular dynamics simulations of DNA/PEI complexes: effect of PEI branching and protonation stateEthylenediamine functionalized-single-walled nanotube (f-SWNT)-assisted in vitro delivery of the oncogene suppressor p53 gene to breast cancer MCF-7 cells.The promise of gene therapy in gastrointestinal and liver diseases.Current status and future prospects of gene therapy technologies toward the treatment of intractable skin diseases.High-efficiency gene transfer into skeletal muscle mediated by electric pulses.Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.Gene-directed enzyme prodrug therapy: a review of enzyme/prodrug combinations.Systematic coarse-grained modeling of complexation between small interfering RNA and polycationsA Pilot Study Evaluating Combinatorial and Simultaneous Delivery of Polyethylenimine-Plasmid DNA Complexes Encoding for VEGF and PDGF for Bone Regeneration in Calvarial Bone DefectsMatrices and scaffolds for DNA delivery in tissue engineeringPolymers for DNA delivery.Imaging gene delivery with fluorescence microscopy.Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene.Tumour and dendrimers: a review on drug delivery aspects.A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread.Subtle changes to polymer structure and degradation mechanism enable highly effective nanoparticles for siRNA and DNA delivery to human brain cancer.Correction of renal tubular acidosis in carbonic anhydrase II-deficient mice with gene therapy.Commercialization of nanotechnology.Gene therapy for the treatment of chronic peripheral nervous system pain.New Transfection Agents Based on Liposomes Containing Biosurfactant MEL-ATarget cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system.HIF1A overexpression using cell-penetrating DNA-binding protein induces angiogenesis in vitro and in vivo.Non-viral transfection methods optimized for gene delivery to a lung cancer cell line.Nuclease-resistant DNA via high-density packing in polymeric micellar nanoparticle coronas.Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a DNA carrier in vitro and in vivo.Lipofection of purified adeno-associated virus Rep68 protein: toward a chromosome-targeting nonviral particle.A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy.Tunable pH-sensitive liposomes composed of mixtures of cationic and anionic lipids.
P2860
Q30478942-593C8DEE-0187-4DA8-BABD-FADB9BDAB4A3Q30716866-E8B759E5-3A5F-415B-93AF-87C2B2A50513Q32123447-109C6F61-1A60-4132-8D0F-4BD0C64EB784Q33208598-536EAF6C-386F-46B9-B0AB-FEB055CBB6CCQ33669657-F9F15921-9C7E-4AE3-8A19-81ABD0A5B1C8Q33706885-EF53758E-361F-49D9-B20F-22E5A50195F3Q33715958-F4AB60A8-9174-4E99-9657-58DD4EDB9F36Q33723073-A21A0A82-C01D-41BE-B799-F16FD30A461DQ33889814-A5D1C310-C9B8-43C9-8AC1-EF3F9B5DE027Q34343478-F6B726F8-F8E3-4C0F-B4BC-F5E6BE017BDFQ34398610-FF1D0D32-0C48-4397-9274-A4CB303F4F40Q35051302-38F9D1A0-432F-41EC-B66C-6FFDE7F7A986Q35071587-D668EFE2-9B48-4F8B-8A4F-6E24E5DFCBD9Q35090229-987C98BC-9D36-4A5F-9738-72633AAC355FQ35099789-75EB7282-22D1-451B-A3FD-6598AA750209Q35123357-09F1AB5E-8E52-4E99-96B0-C9E5563BB600Q35193397-C550517F-971C-4281-9A43-C6DE23216377Q36179778-0D8D4CF1-B78B-459D-9771-131FC2C54FDBQ36385485-FCD2D6CD-2E5D-4930-8C5C-3A8F046248ABQ36807759-97F5226B-6D69-44C8-8C6A-65F801477AA2Q36826532-C713CC1E-135D-4051-A7BD-DF9F074F5A20Q37002661-52890F8C-73A8-435E-A6CC-939D26E94319Q37038838-5AAA08B2-A40E-4FFB-8FB5-C617C7489CC3Q37076376-C92189B1-1C4D-4E08-AB7B-AB720C0079B7Q37153089-B4545892-1898-4BD4-8693-B4F5D39D7E4AQ37171165-7F4E9141-1A6C-4BCB-BA63-6F45944590CEQ37311199-24C485A3-E4D8-4C80-A6F8-C4E57A420DEFQ37338449-416B7C19-2C6D-4ED0-9856-5E86FE48D6C8Q37380014-28CFF804-C426-4160-A8FD-A0DCC0D1382FQ37668288-E1327527-49D5-4FA4-B308-727C0270E9DBQ38016275-47DAC5E5-26EE-47EB-BDB6-D371D5A0130FQ38168393-A74FE488-7FC7-4302-852D-7153FC0ED3AFQ38358020-F0864B70-4BAC-44AE-83B8-CA972A9E193BQ38401529-1CE338C9-62EA-4E9E-A7B2-E43DACA69597Q39135338-6AADF7DF-5B64-439C-A94F-5B43FB8D5850Q39308789-2B1E07E8-CF48-4E10-A376-966171FB7968Q39421817-CF9C428B-E97A-4095-BE75-7C2DBEA93E1EQ39580606-294D5F84-8B86-446B-81C9-C229EDFAF70CQ40121811-32CA23A1-2344-45AF-8A3E-50EABA8DDB0DQ40170257-4E228AC9-6FA2-4853-AB98-E0EE3E72996D
P2860
Nonviral gene therapy: the promise of genes as pharmaceutical products.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Nonviral gene therapy: the promise of genes as pharmaceutical products.
@en
type
label
Nonviral gene therapy: the promise of genes as pharmaceutical products.
@en
prefLabel
Nonviral gene therapy: the promise of genes as pharmaceutical products.
@en
P1433
P1476
Nonviral gene therapy: the promise of genes as pharmaceutical products.
@en
P2093
P304
P356
10.1089/HUM.1995.6.9-1129
P577
1995-09-01T00:00:00Z